Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin. - Eid,H.M.; Eritsland,J.; Larsen,J.; Arnesen,H.; Seljeflot,I. (Atherosclerosis, 2003)